Qlaris Bio: Parisa Zamiri, M.D., Ph.D., Appointed To Board Of Directors
By Amit Chowdhry ● Aug 1, 2026
Qlaris Bio, a clinical-stage biotechnology company focused on developing first-in-class therapies for glaucoma, has appointed Parisa Zamiri, M.D., Ph.D., to its board of directors. The appointment comes as Qlaris continues to advance its lead development program, QLS-111, through late-stage clinical trials as a novel therapeutic agent for the treatment of glaucoma.